Cardiovascular Drug Launch Market Potential & Feasibility Assessment – Europe (UK, Germany, France, Spain & Italy)


The client was evaluating a partnership with a US-based Pharma company that has developed a new cardiovascular treatment


The client was seeking to understand the fundamental market opportunity of the product and the feasibility of launching & commercializing it in the European market.

Our Work

10EQS assessed the potential available market for the drug in the UK, Germany, France, Spain, and Italy, including market size & growth, and customers’ willingness to pay. 10EQS further assessed the feasibility of launching & commercializing the product in each of the target countries, covering challenges & opportunities and the reimbursement potential. In addition, 10EQS validated the patient pathways through different medical bodies.

Project Team
  • Ex-GE Healthcare Management Consultant with extensive healthcare & life sciences industry experience
  • 2 Associate Consultants conducting secondary research & supporting content synthesis
  • 10EQS Delivery Operations (=PMO) providing quality assurance, process management, and expert recruitment
  • 10 industry experts
Industry Experts (sample)
  • Consultant Cardiologist in Inherited Cardiac Diseases – University (UK)
  • Cardiologist, Associate Professor of Cardiology – Hospital (Germany)
  • Interventional Cardiologist – Hospital (Italy) 
  • Senior Cardiologist – Cardiologist (France)
  • President-Elect, Cardiovascular Regenerative and Reparative Medicine – Hospital (Spain)


10EQS provided specific go-to-market recommendations for each target country, including key volume and pricing opportunities for the drug. The insights helped the client decide whether to launch the drug.